NASDAQ · Shell Companies

BioPlus Acquisition Corp. (BIOS) Stock

$10.80 -0.05% NASDAQ: BIOS Financial Services

Currently, BioPlus Acquisition Corp. possesses no major active business operations.

Valuation

MetricValue
Price$10.80
Market Cap$209.07M
P/E Ratio1255.23
P/B Ratio28.94
P/S Ratio0.00
EPS (TTM)$0.01
52-Week High$11.68
52-Week Low$10.12
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE2.33%
ROA2.17%
ROCE-0.49%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.02
Current Ratio1.04

Annual Financials (USD)

Metric20162017201820212022
Revenue$936.0M$817.0M$709.0M$0$0
Operating Profit$-78.0M$-53.0M$-108.0M$0$-1.0M
Net Profit$-34.0M$-131.0M$-52.0M$0$5.0M
EPS$-0.37$-1.06$-0.40$-0.02$0.20
Op Margin-8.3%-6.5%-15.3%——

Balance Sheet (USD)

Metric20162017201820212022
Total Assets$608.0M$603.0M$584.0M$236.0M$238.0M
Total Liabilities$567.0M$606.0M$635.0M$15.0M$15.0M
Cash$10.0M$40.0M$15.0M$1.0M$0
Borrowings$452.0M$481.0M$505.0M$5.0M$5.0M

Latest News

Neurocrine Biosciences (NBIX) Appoints Samir Siddhanti As Chief Business Officer Simply Wall St. · Jul 22, 2026 AGIO Shares Sink Nearly 7% After Scrapping the Tebapivat SCD Program Zacks · Jul 22, 2026 Here's Why You Should Add Savara Stock to Your Portfolio Now Zacks · Jul 22, 2026 NBIX: Raising target price to $197.00 Argus Research · Jul 22, 2026 Neurocrine Biosciences Appoints Samir Siddhanti as Chief Business Officer MT Newswires · Jul 21, 2026

Cash Flow (USD)

Metric20162017201820212022
Operating Cash Flow$-43.0M$-1.0M$-20.0M$0$-1.0M
Investing Cash Flow$-83.0M$-22.0M$-27.0M$0$0
Financing Cash Flow$193.0M$65.0M$8.0M$0$0
Net Cash Flow$-6.0M$30.0M$-26.0M$0$0
Free Cash Flow$-52.0M$-9.0M$-34.0M$0$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.08
EV / EBITDA-182.69
FCF Yield-0.33%
Quick Ratio1.04
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About BioPlus Acquisition Corp.

Currently, BioPlus Acquisition Corp. possesses no major active business operations. Its express mandate is to pursue and complete a strategic combination, which may take the form of a merger, share exchange, asset purchase, stock acquisition, reorganization, or similar transaction. This targeted consolidation is specifically aimed at one or more entities within the vibrant life sciences industry. The corporation was formally established in 2021 and maintains its principal executive offices in New York, New York.

BioPlus Acquisition Corp. is headquartered in US.

BioPlus Acquisition Corp. (BIOS) stock trades at $10.80 with a market capitalization of $209.07M. The stock is valued at a price-to-earnings (P/E) ratio of 1255.23, price-to-book of 28.94, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $10.12 and $11.68, and currently trades 7.5% below its 52-week high.

On profitability, BioPlus Acquisition Corp. generates a return on equity (ROE) of 2.33%, return on capital employed of -0.49%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: bioplusspac.com

Related Financial Services Stocks

BRK.A Insurance - Diversified $733370.00 +0.00% BRK.B FIRE, MARINE & CASUALTY INSURANCE $482.70 +0.00% JPM Banks - Diversified $357.52 +0.34% V Financial - Credit Services $362.50 -2.15% MA Financial - Credit Services $562.95 -2.26% BAC Banks - Diversified $63.17 +0.27% HSBC Banks - Diversified $102.60 -1.06% MS Financial - Capital Markets $203.19 -3.97% GS Financial - Capital Markets $980.75 -5.09% RY Banks - Diversified $206.45 -2.79% WFC Banks - Diversified $83.87 -3.45% MUFG Banks - Diversified $21.94 -2.18%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)Exxon Mobil (XOM)

Screens featuring this stock

High ROE Financial Services StocksLow P/E Financial Services StocksHigh Net Margin Financial Services StocksDividend Financial Services StocksLow Debt Financial Services StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides